GlaxoSmithKline Pharmaceuticals Limited — Others, 03-06-2025: Shareholders meeting

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company will hold its 100th Annual General Meeting via video conferencing, seeking shareholder approval for a final dividend of ₹42 per share. Dr. (Ms.) Sunita Maheshwari is proposed for re-appointment as an Independent Director for another three-year term, highlighting her strategic role. Parikh & Associates have been appointed as Secretarial Auditors for five years starting FY2025-26, and the remuneration of ₹7.35 lakhs for Cost Auditors R. Nanabhoy & Company is up for ratification, emphasizing governance and compliance.